FirstLook uses a unique, advanced technology that analyzes DNA fragment patterns to screen for lung cancer.3
FirstLook makes lung cancer screening accessible to all eligible adults by keeping the process simple.
The FirstLook blood test can be incorporated into routine appointments, making it easier for more adults to get screened for lung cancer.
Whether it’s due to inaccessible screening methods or lack of awareness, the vast majority of eligible adults aren’t getting the nationally recommended low-dose CT screening.5
The FirstLook blood test offers a convenient and accessible way to enhance lung cancer screening.
*The negative predictive value represents the percentage of individuals with a Not Elevated result who do not have low-dose CT detectable lung cancer. The clinical validity of FirstLook Lung was established by a prospective, case-controlled study in a population of screen-eligible patients. FirstLook Performance: Data on File.3
1. National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 365(5), 395-409. 2. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, Tammemägi MC, Hazelton WD, Feuer EJ, McMahon PM. (2014). Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med, 160(5), 311-20. 3. FirstLook Performance: Data on File. DELFI Diagnostics, Inc. 4. Meza, R., Jeon, J., Toumazis, I., Ten Haaf, K., Cao, P., Bastani, M., Han, S. S., Blom, E. F., Jonas, D. E., Feuer, E. J., Plevritis, S. K., de Koning, H. J., & Kong, C. Y. (2021). Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. JAMA, 325(10), 988–997. 5. Wang GX, Baggett TP, Pandharipande PV, Park ER, Percac-Lima S, Shepard JO, Fintelmann FJ, Flores EJ. Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective. (2019). Radiology, 290(2), 278-287.